The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sivertseva S.A.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza

Prilenskaya A.M.

Tyumen Regional Center of Multiple Sclerosis, Tyumen, Russia

Sivertsev M.Iu.

Poliklinika konsul'tativno-diagnosticheskaia im. E.M. Niginskogo, Tiumen'

Bazhukhin D.V.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza, Tiumen'

Smirnova N.F.

Kafedra nevrologii, neĭrokhirurgii i meditsinskoĭ genetiki lechebnogo fakul'teta GOU VPO "Rossiĭskiĭ nauchno-issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova" Minzdrava Rossii

Guseva M.E.

GBOU VPO «Rossiĭskiĭ natsionalnyĭ issledovatelskiĭ meditsinskiĭ universitet im. N.I. Pirogova», Moskva

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

The risk of ischemic stroke in patients with multiple sclerosis

Authors:

Sivertseva S.A., Prilenskaya A.M., Sivertsev M.Iu., Bazhukhin D.V., Smirnova N.F., Guseva M.E., Boĭko A.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8‑2): 88‑94

DOI: 10.17116/jnevro201811808288

Read: 4839 times

Download PDF (RU)
Contact the author
Table of contents

THE RISK OF ISCHEMIC STROKE IN PATIENTS WITH MULTIPLE SCLEROSIS
THE RISK OF ISCHEMIC STROKE IN PATIENTS WITH MULTIPLE SCLEROSIS

To cite this article:

Sivertseva SA, Prilenskaya AM, Sivertsev MIu, Bazhukhin DV, Smirnova NF, Guseva ME, Boĭko AN. The risk of ischemic stroke in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8‑2):88‑94. (In Russ.)
https://doi.org/10.17116/jnevro201811808288

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Diagnostic value of cross-sectional imaging moda­lities in asse­ssment of peri­toneal carcinomatosis. P.A. Herzen Journal of Onco­logy. 2024;(5):82-88
Adva­nces in thro­mbectomy in the acute ischemic stroke. Russian Journal of Preventive Medi­cine. 2024;(10):137-143
Low-level laser therapy in multiple scle­rosis: justification and opti­mization methods of application. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):45-56
Brain magnetic reso­nance imaging features in Leber’s here­ditary optic neuropathy. Russian Annals of Ophthalmology. 2024;(5):146-153
Improving the effe­ctiveness of treatment of patients with post-stroke apha­sia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):22-28
Glial fibrillary acidic protein: is there a rela­tionship with the course of multiple scle­rosis and traumatic brain injury before the onset of multiple scle­rosis?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):80-84
An indi­vidual approach to the diagnosis and treatment of an acute psychotic condition in a patient with a multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):97-102
Type and sex variability of dime­nsional characteristics of the fourth ventricle of the rhomboid brain acco­rding to MRT. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(4):43-48
The effe­ctiveness of drug therapy in the reha­bilitation of patients with post-stroke apha­sia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):132-139
Surgical treatment of seco­ndary trigeminal neuralgia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):203-209
Abstract:

A brief literature review on risk factors of ischemic stroke in patients with multiple sclerosis (MS) is presented. A case of ischemic stroke in a MS patient was demonstrated, and risk factors were identified.

Keywords:

multiple sclerosis
ischemic stroke
magnetic resonance imaging

Authors:

Sivertseva S.A.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza

Prilenskaya A.M.

Tyumen Regional Center of Multiple Sclerosis, Tyumen, Russia

Sivertsev M.Iu.

Poliklinika konsul'tativno-diagnosticheskaia im. E.M. Niginskogo, Tiumen'

Bazhukhin D.V.

Tiumenskiĭ oblastnoĭ tsentr rasseiannogo skleroza, Tiumen'

Smirnova N.F.

Kafedra nevrologii, neĭrokhirurgii i meditsinskoĭ genetiki lechebnogo fakul'teta GOU VPO "Rossiĭskiĭ nauchno-issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova" Minzdrava Rossii

Guseva M.E.

GBOU VPO «Rossiĭskiĭ natsionalnyĭ issledovatelskiĭ meditsinskiĭ universitet im. N.I. Pirogova», Moskva

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Close metadata

References:

  1. Boyko AN, Bykova OV, Sibertseva SA. Multiple sclerosis in childhood and adolescence (clinic, diagnosis, treatment). M.: MIA; 2016. (In Russ.)
  2. LeVine SM. Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered? Front of Neurol. 2016;11;7:128. https://doi.org/10.3389/fneur.2016.00128
  3. D’haeseleer M1, Cambron M, Vanopdenbosch L, De Keyser J. Vascular aspects of multiple sclerosis. The Lancet Neurology. 2011;10(7):657-666. https://doi.org/10.1016/S1474-4422(11)70105-3
  4. Wang Y, Bos SD, Harbo HF, Thompson WK, Schork AJ, Bettella F, Witoelar A, Lie BA, Li W, McEvoy LK, Djurovic S, Desikan RS, Dale AM, Andreassen OA. Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors. Multiple Scler J. 2016;22(14):1783-1793. https://doi.org/10.1177/1352458516635873
  5. Thormann A, Magyari M, Koch-Henriksen N, Laursen B, Sørensen PS. Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark. J of Neurol. 2016;263(12):2484-2493. https://doi.org/10.1007/s00415-016-8295-9
  6. Peeters PJ, Bazelier MT, Uitdehaag BM, Leufkens HG, De Bruin ML, de Vries F. The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink. J Thromb Haemost. 2014;12(4):444-451. https://doi.org/10.1111/jth.12523
  7. Tseng CH, Huang WS, Lin CL, Chang YJ. Increased risk of ischaemic stroke among patients with multiple sclerosis. Eur J of Neurol. 2015;22(3):500-506. https://doi.org/10.1111/ene.12598
  8. Kang JH, Chen YH, Lin HC. Comorbidities amongst patients with multiple sclerosis: a population-based controlled study. Eur J of Neurol. 2010;17(9):1215-1219. https://doi.org/10.1111/j.1468-1331.2010.02971.x
  9. Christiansen CF, Christensen S, Farkas DK, Miret M, Sørensen HT, Pedersen L. Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study. Neuroepidemiology. 2010;35(4):267-274. https://doi.org/10.1159/000320245
  10. Roshanisefat H, Bahmanyar S, Hillert J, Olsson T, Montgomery S. Multiple sclerosis clinical course and cardiovascular disease risk — Swedish cohort study. Eur J of Neurol. 2014;21(11):1353-1388. https://doi.org/10.1111/ene.12518
  11. Fleming ST, Blake RL Jr. Patterns of comorbidity in elderly patients with multiple sclerosis. J of Clin Epidemiol. 1994;47(10):1127-1132. https://doi.org/10.1016/0895-4356(94)90099-X
  12. Allen NB, Lichtman JH, Cohen HW, Fang J, Brass LM, Alderman MH. Vascular disease among hospitalized multiple sclerosis patients. Neuroepidemiology. 2008;30(4):234-238. https://doi.org/10.1159/000128103
  13. Jadidi E, Mohammadi M, Moradi T. High risk of cardiovascular diseases after diagnosis of multiple sclerosis. Mult Scler J. 2013;19(10):1336-1340. https://doi.org/10.1177/1352458513475833
  14. Moccia M, Lanzillo R, Palladino R, Russo C, Carotenuto A, Massarelli M, Vacca G, Vacchiano V, Nardone A, Triassi M, Morra VB. Uric acid: a potential biomarker of multiple sclerosis and of its disability. Clin Chem Lab Med. 2015;53(5):753-759. https://doi.org/10.1515/cclm-2014-0744
  15. Constantinescu CS, Freitag P, Kappos L. Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis. Mult Scler J. 2000;6(6):378-381. https://doi.org/10.1177/135245850000600603
  16. Toncev G, Milicic B, Toncev S, Samardzic G. High-dose methylprednisolone therapy in multiple sclerosis increases serum uric acid levels. Clin Chem Lab Med. 2002;40(5):505-508. https://doi.org/10.1515/CCLM.2002.088
  17. D’haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J. Vascular aspects of multiple sclerosis. The Lancet Neurology. 2011;10(7):657-66. https://doi.org/10.1016/S1474-4422(11)70105-3
  18. Kaplan TB, Berkowitz AL, Samuels MA. Cardiovascular Dysfunction in Multiple Sclerosis. The Neurologist. 2015;20(6):108-114. https://doi.org/10.1097/NRL.0000000000000064
  19. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. The Lancet Neurology. 2010;9(6):599-612. https://doi.org/10.1016/S1474-4422(10)70086-7
  20. McGreevy C, Williams D. New insights about vitamin D and cardiovascular disease: a narrative review. Ann Int Med. 2011;155(12):820-826. https://doi.org/10.7326/0003-4819-155-12-201112200-00004
  21. Saindane AM, Law M, Ge Y, Johnson G, Babb JS, Grossman RI. Correlation of diffusion tensor and dynamic perfusion MR imaging metrics in normal-appearing corpus callosum: support for primary hypoperfusion in multiple sclerosis. Am J Neuroradiol. 2007;28(4):767-772. http://www.ajnr.org/content/28/4/767.long
  22. De Keyser J, Steen C, Mostert JP, Koch MW. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. Journal of Cerebral Blood Flow and Metabolism. 2008;28(10):1645-1651. https://doi.org/10.1038/jcbfm.2008.72
  23. Haufschild T, Shaw SG, Kesselring J, Flammer J. Increased endothelin-1 plasma levels in patients with multiple sclerosis. J Neuroophthalmol. 2001;21(1):37-38. https://www.ncbi.nlm.nih.gov/pubmed/11315981
  24. Speciale L, Sarasella M, Ruzzante S, Caputo D, Mancuso R, Calvo MG, Guerini FR, Ferrante P. Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis. J Neurovirol. 2000;6(suppl 2):62-66. https://www.ncbi.nlm.nih.gov/pubmed/10871788
  25. Pache M, Kaiser HJ, Akhalbedashvili N, Lienert C, Dubler B, Kappos L, Flammer J. Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis. Eur Neurol. 2003;49(3):164-168. https://doi.org/10.1159/000069085
  26. Inglese M, Adhya S, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. Journal of Cerebral Blood Flow and Metabolism. 2008;28(1):164-171. https://doi.org/10.1038/sj.jcbfm.9600504
  27. Marrie RA, Reider N, Cohen J, Stuve O, Trojano M, Cutter G, Reingold S, Sorensen PS. A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler J. 2015;21(3):318-331. https://doi.org/10.1177/1352458514564485
  28. Fu Y, Liu Q, Anrather J, Shi FD. Immune interventions in stroke. Nat Rev Neurol. 2015;11(9):524-535. https://doi.org/10.1038/nrneurol.2015.144
  29. Liesz A, Zhou W, Mracskó É, Karcher S, Bauer H, Schwarting S, Sun L, Bruder D, Stegemann S, Cerwenka A, Sommer C, Dalpke AH, Veltkamp R. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain. 2011;134(3):704-720. https://doi.org/10.1093/brain/awr008
  30. Rolland WB, Lekic T, Krafft PR, Hasegawa Y, Altay O, Hartman R, Ostrowski R, Manaenko A, Tang J, Zhang JH. Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhage. Experimental Neurol. 2013;241:45-55. https://doi.org/10.1016/j.expneurol.2012.12.009
  31. Rolland WB 2nd, Manaenko A, Lekic T, Hasegawa Y, Ostrowski R, Tang J, Zhang JH. FTY720 is neuroprotective and improves functional outcomes after intracerebral hemorrhage in mice. Acta Neurochir Suppl. 2011;111:213-217. https://doi.org/10.1007/978-3-7091-0693-8_36
  32. Li YJ, Chang GQ, Liu Y, Gong Y, Yang C, Wood K, Shi FD, Fu Y, Yan Y. Fingolimod alters inflammatory mediators and vascular permeability in intracerebral hemorrhage. Neurosci Bull. 2015;31(6):755-762. https://doi.org/10.1007/s12264-015-1532-2
  33. Ajmo CT Jr, Collier LA, Leonardo CC, Hall AA, Green SM, Womble TA, Cuevas J, Willing AE, Pennypacker KR. Blockade of adrenoreceptors inhibits the splenic response to stroke. Experiment Neurol. 2009;218(1):47-55. https://doi.org/10.1016/j.expneurol.2009.03.044
  34. Sahota P, Vahidy F, Nguyen C, Bui TT, Yang B, Parsha K, Garrett J, Bambhroliya A, Barreto A, Grotta JC, Aronowski J, Rahbar MH, Savitz S. Changes in spleen size in patients with acute ischemic stroke: a pilot observational study. Int J Stroke. 2013;8(2):60-67. https://doi.org/10.1111/ijs.12022
  35. Hug A, Dalpke A, Wieczorek N, Giese T, Lorenz A, Auffarth G, Liesz A, Veltkamp R. Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke. 2009;40(10):3226-3232. https://doi.org/10.1161/STROKEAHA.109.557967
  36. Mracsko E, Liesz A, Karcher S, Zorn M, Bari F, Veltkamp R. Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke. Brain, Behavior and Immunity. 2014;41:200-209. https://doi.org/10.1016/j.bbi.2014.05.015
  37. Wong CH, Jenne CN, Lee WY. Léger C. Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science. 2011;334(6052):101-105. https://doi.org/10.1126/science.1210301
  38. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, Ruscher K, Victorov IV, Priller J, Dirnagl U, Volk HD, Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Expl Med. 2003;198(5):725-736. https://doi.org/10.1084/jem.20021098
  39. Sternberg Z, Leung C, Sternberg D, Yu J, Hojnacki D. Disease Modifying Therapies Modulate Cardiovascular Risk Factors in Patients with Multiple Sclerosis. Cardiovasc Ther. 2014;32:33-39. https://doi.org/10.1111/1755-5922.12049
  40. Wens I, Dalgas U, Stenager E, Eijnde BO. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis- a systematic review. Mult Scler. 2013;19(12):1556-1564. https://doi.org/10.1177/1352458513504252
  41. Wang YF, Chen YT, Luo JC, Chen TJ, Wu JC, Wang SJ. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study. Am J Gastroenteroenterol. 2017;112(7):1084-1093. https://doi.org/10.1038/ajg.2017.101
  42. Sehested TSG, Gerds TA, Fosbøl EL, Hansen PW, Charlot MG, Carlson N, Hlatky MA, Torp-Pedersen C, Gislason GH. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction. J Int Med. 2018;283(3):268-281. https://doi.org/10.1111/joim.12698
  43. Dulicek P, Ivanova E, Kostal M, Sadilek P, Beranek M, Zak P, Hirmerova J. Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use. Clin Appl Thromb Hemost. 2017;34:231-236. https://doi.org/10.1177/1076029617727857
  44. Gorenoi V, Schönermark MP, Hagen A. Benefits and risks of hormonal contraception for women. GMS Health Technology Assessment. 2007;3:Doc06. https://www.ncbi.nlm.nih.gov/pubmed/21289940
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.